NYXIO TECHNOLOGIES Corp

CIK:0001373761|SEC Filings

Statements of Operations (USD $)	3 Months Ended		9 Months Ended
Statements of Operations (USD $)	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]
Revenue	$ 5,676		$ 5,676	$ 6,065
Cost of goods sold	2,829		2,829	1,445
Gross profit (loss)	2,847		2,847	4,620
Operating expenses
Consulting services	85,299	318,042	193,142	389,042
Depreciation	2,333	2,637	7,561	8,481
General and administrative	12,127	1,438	26,866	9,392
Professional fees	72,950	81,438	177,465	108,957
Promotional and marketing	11,483		14,114	45
Research and development
Rent expense	2,825	5,499	7,055	10,153
Salaries and wages	60,504	62,500	187,500	94,987
Officer compensation	1,250,000	1,250,000	3,750,000	3,979,167
Travel and entertainment	11,099	947	16,474	4,541
Impairment
Total operating expenses	1,508,620	1,722,501	4,380,177	4,604,765
Net loss from operations	(1,505,773)	(1,722,501)	(4,377,330)	(4,600,145)
Other income (expense)
Amortization of debt discounts	(125,375)	(44,070)	(384,901)	(219,116)
Financing costs	(49,854)	(7,000)	(55,894)	(316,768)
Interest expense	(13,306)	(63,657)	(56,048)	(85,289)
Interest expense - related party	(243)	(439)	(666)	(649)
Other income	1		3
Gain (loss) on derivatives	906,405	(171,266)	249,377	(254,951)
Gain (loss) on debt settlement			14,461
Total other income (expense)	717,628	(286,432)	(233,668)	(876,773)
Net loss	$ (788,145)	$ (2,008,933)	$ (4,610,998)	$ (5,476,918)
Basic and fully diluted loss per common share	$ 0.00	$ (0.03)	$ 0.00	$ (0.15)
Basic and fully diluted - weighted average common shares outstanding	3,634,702,298	74,770,313	2,034,307,114	35,969,456

Statements of Cash Flows (USD $)	9 Months Ended
Statements of Cash Flows (USD $)	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net (loss)	$ (4,610,998)	$ (5,476,918)
Adjustments to reconcile net (loss) to net cash used by operating activities:
Depreciation	7,561	8,481
Shares and options issued for services	3,883,500	4,486,207
Shares issued for financing costs		306,770
Amortization of beneficial conversion	384,901	219,116
Penalty interest on default of convertible debt	15,243	51,550
(Gain) loss on derivatives	(249,377)	254,951
Warrants issued for finance charges	49,854
Decrease (increase) in assets:
Accounts receivable	223
Deposits on Inventory	(16,004)
Increase (decrease) in liabilities:
Accounts payable and accrued expenses	241,407	(68,112)
Accrued interest	27,010	44,785
Deferred revenue	(5,676)
Net cash used in operating activities	(272,356)	1,835,763
Cash flows from investing activities:
Change in due from related party, net		27,177
Purchase of fixed assets	(474)	(300)
Net cash provided by (used in) in investing activities	(474)	26,877
Cash flows from financing activities:
Proceeds from notes payable - related party	3,000
Payments on notes payable - related party	(1,000)
Proceeds from convertible debt	247,125	145,250
Proceeds from the sale of common stock
Net cash provided by financing activities	249,125	145,250
Net increase (decrease) in cash	(23,705)	2,007,890
Cash, beginning of period	27,082	2,658
Cash, end of period	337	2,010,548
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest

Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Assets
Cash	$ 3,377	$ 27,082
Accounts receivable		223
Deposots on Inventory	16,004
Total current assets	19,381	27,305
Fixed assets, net of accumulated depreciation of $38,346 and $30,785, respectively	8,234	15,321
Total assets	27,615	42,626
Current liabilities
Accounts payable and accrued expenses	689,631	567,598
Accrued interest	145,506	131,741
Deferred revenue	19,324	25,000
Notes payable	171,630	171,630
Notes payable - related party	10,458	8,458
Convertible notes payable, net of discounts of $255,946 and $61,842, respectively	128,995	328,361
Warrant liability	49,854
Derivative liability	170,768	505,647
Total current liabilities	1,386,166	1,738,435
Shareholders (deficit)
Series A preferred stock; $0.01 par value; 1,100 shares authorized; no shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively
Series B preferred stock; $0.01 par value; 100 shares authorized; shares 100 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively	1	1
Common stock; $0.001 par value; 5,000,000,000 shares authorized; 4,188,001,232 and 335,994,983 shares authorized and issued at September 30, 2014 and December 31, 2013, respectively	4,188,002	335,995
Common shares sold and unissued, 1,666 at September 30, 2014 and December 31, 2013, respectively	2	2
Additional paid-in capital	16,582,887	19,322,140
Common stock payable	50,000	50,000
Deferred compensation	(3,020,833)	(6,770,833)
Other comprehensive income (loss)		(85,502)
Accumlated (deficit)	(19,158,610)	(14,547,612)
Total shareholders (deficit)	(1,358,551)	(1,695,809)
Total liabilities and shareholders (deficit)	$ 27,615	$ 42,626